thoracoabdominal emergencies iii | free radiology cme
Published 1 year ago • 730 plays • Length 17:09Download video MP4
Download video MP3
Similar videos
-
0:57
choosing between tas-102 and regorafenib in colorectal cancer
-
1:36
phase 3 trial investigates t-dm1 and pertuzumab in her2 breast cancer
-
3:51
study comparing margetuximab combinations to trastuzumab combinations in her2-positive breast cancer
-
1:10
dr. hamilton on the fda approval of tucatinib in her2 breast cancer
-
1:29
bispecific bcma-cd3 antibody teclistamab is efficacious and tolerable in r/r mm
-
1:30
triplet combinations in flt3-mutated aml
-
21:16
partner 2a and sapien 3 results: future of tavr
-
2:49
management of side effects with tas-102
-
47:15
2d to 3d ebrt | session 11 | reviewing portal images (practical basic cases)
-
21:41
the future in multiple myeloma: bite immunotherapy, car-t, and immune checkpoint inhibitors
-
23:32
tavr update 2016
-
1:42:20
2d to 3d ebrt | session 22 | 2nd check software
-
0:55
covid-19: 3,528 new cases bring total to 2,735,241
-
5:42
role of tas-102 (trifluridine/tipiracil) in advanced colorectal cancer
-
3:51:33
3ª turma do trf1 03/10/2023
-
1:18
dr. mehta on rationale for a phase ii trial of tas-102/ramucirumab in gastric/gej cancer
-
57:35
exam readiness 3ab, 3cd and 2cd
-
5:15
brca-mutated triple-negative breast cancer
-
1:23:07
p3 git for frcr(part 2)
-
4:18
phase 3 recourse trial of tas-102 vs placebo
-
1:45:02
3ª turma do trf1 19/04/2022
-
5:25
her2climb fda approval